PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22038446-9	2012	TGF-beta1 serum concentrations were higher at 48 weeks after surgery in patients with enoxaparin.	Enoxaparin	86-96	transforming growth factor beta 1	Homo sapiens	0-9	
17389624-0	2007	Enoxaparin but not unfractionated heparin causes a dose-dependent increase in plasma TGF-beta 1 during haemodialysis: a cross-over study.	Enoxaparin	0-10	transforming growth factor beta 1	Homo sapiens	85-95	
17389624-2	2007	In this cross-over study, we compared the effects of enoxaparin and unfractionated heparin (UFH) used as anticoagulants during haemodialysis (HD) on plasma TGF-beta1 levels and some platelet activation markers: platelet-derived growth factor-AB (PDGF-AB), beta-thromboglobulin (beta-TG) and platelet factor-4 (PF-4).	Enoxaparin	53-63	transforming growth factor beta 1	Homo sapiens	156-165	
17389624-6	2007	RESULTS: Pre-dialysis, TGF-beta1 levels tended to be lower in patients anticoagulated with enoxaparin compared with UFH [6.9 (3.3-21.9) ng/ml vs 8.4 (3.8-30.2) ng/ml, respectively; P = 0.05].	Enoxaparin	91-101	transforming growth factor beta 1	Homo sapiens	23-32	
17389624-8	2007	The 35% increase in plasma TGF-beta1 after 180 min of HD positively correlated with the enoxaparin dose/kg (r = 0.553, P = 0.008) and, interestingly, negatively with the baseline level of the cytokine (r = -0.544, P = 0.009).	Enoxaparin	88-98	transforming growth factor beta 1	Homo sapiens	27-36	
17389624-10	2007	CONCLUSION: Enoxaparin, compared with UFH, induces a rapid overdialytic but not sustained increase in plasma TGF-beta1 levels.	Enoxaparin	12-22	transforming growth factor beta 1	Homo sapiens	109-118